Skip to ContentSkip to Navigation
Over onsFaculty of Science and EngineeringOnderzoekGRIPPharmacoTherapy, -Epidemiology & -Economics (PTEE)Publications

Publications 2012

Below our publications are listed using several headings. Scientific publications relate to original research, often published internationally, but also in the Dutch language. Professional publications are in Dutch and relate to reviews and expressions of opinions.

A few publications have no links. Reprints can be requested by our secretary

Scientific publication international

1

Bakir M, Standaert B, Turel O, Bilge E, Postma M. Estimating and comparing the clinical and economic impact of paediatric rotavirus vaccination in turkey using a simple versus an advanced model. Vaccine, In Press, Uncorrected Proof, Available online 6 December 2012

Bijlsma MJ , Hak E, Bos JH, de Jong-van den Berg LTW, Janssen F. Inclusion of the birth cohort dimension improved description and explanation of trends in statin use. J Clin Epidemiol 2012; Oct;65(10):1052-60.

3

Brouwers JR , van Ojik AL, van Roon EN,Jansen PA. Authors' reply to pergolizzi: "treatment of chronic pain in older people: evidence-based choice of strong-acting opioids". Drugs Aging 2012;29(12):997-8

4

Chedoe I , Molendijk H, Hospes W, Van den Heuvel ER, Taxis K. The effect of a multifaceted educational intervention on medication preparation and administration errors in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed 2012; Apr 5; DOI: 10.1136/fetalneonatal-2011-300989.

5

Connolly MP , Boersma C, Oldenburg B. The economics of mesalazine in active ulcerative colitis and maintenance in the Netherlands. Neth J Med 2012; Aug;70(6):272-7.

6

Connolly MP , Topachevskyi O, Standaert B, Ortega O, Postma M. The impact of rotavirus vaccination on discounted net tax revenue in egypt: a government perspective analysis. Pharmacoeconomics 2012; Aug 1;30(8):681-95.

7

Crijns HJ , van Rein N, Gispen-de Wied CC, Straus SM, de Jong-van den Berg LTW. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study. Pharmacoepidemiol Drug Saf 2012; 21(10):1060-6

8

Crijns I , Bos J, Knol M, Straus S, de Jong-van den Berg LTW. Paternal drug use: before and during pregnancy. Expert Opin Drug Saf 2012; Jul;11(4):513-8.

9

Crijns I , Straus S, Luteijn M, Gispen-de Wied C, Raine J, de Jong-van den Berg LTW. Implementation of the Harmonized EU Isotretinoin Pregnancy Prevention Programme: A Questionnaire Survey among European Regulatory Agencies. Drug Saf 2012; Nov 3;35(1):27-32.

10

de Jong J , Bos JH, de Vries TW, de Jong-van den Berg LTW. Antibiotic use in children and the use of medicines by parents. Arch Dis Child 2012; Jun;97(6):578-81.

11

de Jonge L , Langenburg AM, Ensing JG, Boek CM, Pras N, Loonen AJ. Psychotropic drugs dispensed on the Island of Bonaire. Tijdschr Psychiatr 2012;54(1):81-7.

12

de Vries FM, Denig P, Pouwels KB, Postma MJ,Hak E. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis. Drugs 2012;72(18):2365-733492

13

Farkouh RA, Klok RM, Postma MJ, Roberts CS,Strutton DR. Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions. Expert Rev Vaccines 2012;11(10):1235-473493

14

Fugel HJ , Nuijten M, Postma M. Stratified medicine and reimbursement issues. Front Pharmacol 2012;3:181.

15

Gefenaite G , Smit M, Nijman HW, Tami A, Drijfhout IH, Pascal A, Postma MJ, Wolters BA, van Delden JJ, Wilschut JC, Hak E. Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents. BMC Public Health 2012; Jul 2;12:498.

16

Geurts MM , Talsma J, Brouwers JRBJ, de Gier JJ. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol 2012; Jul;74(1):16-33.

17

Härmark L , Alberts S, van Puijenbroek E, Denig P, van Grootheest K. Representativeness of diabetes patients participating in a web-based adverse drug reaction monitoring system. Pharmacoepidemiol Drug Saf 2012; DOI: 10.1002/pds.3341. [Epub ahead of print]

18

Härmark L , Lie-Kwie M, Berm L, de Gier H, van Grootheest K. Patients' motives for participating in active post-marketing surveillance. Pharmacoepidemiol Drug Saf 2012; DOI: 10.1002/pds.3327.

19

Härmark L , van Grootheest K. Web-based intensive monitoring: from passive to active drug surveillance. Expert Opin Drug Saf 2012; Jan;11(1):45-51.

20

Härmark L , van Puijenbroek E, van Grootheest K. Intensive monitoring of duloxetine: results of a web-based intensive monitoring study. Eur J Clin Pharmacol 2012 Jun 12. [Epub ahead of print]

21

Harrison-Woolrych M , Harmark L, Tan M, Maggo S, van Grootheest K. Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres. Eur J Clin Pharmacol 2012; Jul;68(7):1065-72.

22

Ivanova SA , Al Hadithy AF, Brazovskaya N, Semke A, Wilffert B, Fedorenko O, Brouwers JR, Loonen AJ. No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia. Hum Psychopharmacol 2012; May;27(3):334-7.

23

Ivanova SA , Loonen AJ, Pechlivanoglou P, Freidin MB, Al Hadithy AF, Rudikov EV, Zhukova IA, Govorin NV, Sorokina VA, Fedorenko OY, Alifirova VM, Semke AV, Brouwers JR, Wilffert B. NMDA receptor genotypes associated with the vulnerability to develop dyskinesia. Transl Psychiatry 2012 Jan 10;2:e67. DOI: 10.1038/tp.2011.66. [Epub ahead of print]

24

Janssen F, Spriensma A. 'The contribution of smoking to regional mortality differences in the Netherlands'. Demographic Research 2012;27:233-60.

25

Jentink J , Boersma C, de Jong-van den Berg LTW, Postma MJ. Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomes. J Med Econ 2012;15(5):862-8.

26

Keijsers CJ , van Hensbergen L, Jacobs L, Brouwers JRBJ, de Wildt DJ, Ten Cate OT, Jansen PAF. Geriatric pharmacology and pharmacotherapy education for health professionals and students: a systematic review. Brit J Clin Pharmacol. 2012 Mar 15. DOI:10.1111/j1365-2125.2012.04268.x[Epub ahead of print].

27

Koning JP , Vehof J, Burger H, Wilffert B, Al Hadithy A, Alizadeh B, van Harten PN, Snieder H. Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients. Psychopharmacology (Berl) 2012; Feb;219(3):727-36.

28

Koopmans PC , Bos JH, de Jong van den Berg LTW. Are antibiotics related to oral combination contraceptive failures in the Netherlands? A case-crossover study. Pharmacoepidemiol Drug Saf 2012; Aug;21(8):865-71.

29

Lako IM , Bruggeman R, Knegtering H, Wiersma D, Schoevers RA, Slooff CJ, Taxis K. A systematic review of instruments to measure depressive symptoms in patients with schizophrenia. J Affect Disord. 2012 Sep;140(1):38-47.

30

Lako IM , Taxis K, Bruggeman R, Knegtering H, Burger H, Wiersma D, Slooff CJ. The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study. Eur Psychiatry. 2012 May;27(4):240-4.

31

Liu WM , Nahar TE, Jacobi RH, Gijzen K, van Beek J, Hak E, Jonges M, Boog CJ, van der Zeijst BA, Soethout EC. Impaired production of TNF-alpha by dendritic cells of older adults leads to a lower CD8+ T cell response against influenza. Vaccine 2012; Feb 21;30(9):1659-66.

32

Loonen AJ , Leonard BE, van Praag HM. Little hope for further innovations in psychopharmacology?. Hum Psychopharmacol 2012; Sep;27(5):437-9.

33

Lugner AK , van Boven M, de Vries R, Postma MJ, Wallinga J. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ 2012 Jul 12;345:e4445. DOI: 10.1136/bmj.e4445.

34

Meijboom MJ , Rozenbaum MH, Benedictus A, Luytjes W, Kneyber MC, Wilschut JC, Hak E, Postma MJ. Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands. Vaccine 2012;29;30(31):4691-700

35

Monteiro SP , Dijk LV, Verstraete AG, Alvarez FJ, Heissing M, de Gier JJ. Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey. BMC Public Health 2012; Jan 20;12(1):59.

36

Munster JM , Leenders AC, Hamilton CJ, Hak E, Aarnoudse JG, Timmer A. Placental histopathology after Coxiella burnetii infection during pregnancy. Placenta 2012; Feb;33(2):128-31.

37

Munster JM , Steggerda LM, Leenders AC, Aarnoudse JG, Hak E. Screening for Coxiella burnetii infection during pregnancy: pros and cons according to the Wilson and Jungner criteria. Euro Surveill 2012; Jan 19;17(3):20061.

38

Nguyen HT , Wirtz VJ, Haaijer-Ruskamp FM, Taxis K. Indicators of quality use of medicines in South-East Asian countries: a systematic review, Trop Med Int Health 2012 Sep 14. DOI: 10.1111/j.1365-3156.2012.03081.x. [Epub ahead of print]

39

Nygard P , Jansman FG, Kruik-Kolloffel WJ, Barnaart AF, Brouwers JRBJ. Effects of short-term addition of NSAID to diuretics and/or RAAS-inhibitors on blood pressure and renal function. Int J Clin Pharm 2012; Jun;34(3):468-74.

40

Oosterhuis I , van Hunsel FP, & van Puijenbroek EP. (2012). Expectations for feedback in adverse drug reporting by healthcare professionals in the netherlands. Drug Saf, 35(3), 221-232.

41

Pierik JG , Gumbs PD, Fortanier SA, Van Steenwijk PC, Postma MJ. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis 2012 May 10;12:110. DOI: 10.1186/1471-2334-12-110.

42

Pitman R , Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, Brisson M. Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5. Value Health 2012; Sep;15(6):828-34.

43

Pitman R , Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, Brisson M. Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5. Med Decis Making 2012; Sep;32(5):712-21.

44

Posthumus AA , Alingh CC, Zwaan CC, van Grootheest KK, Hanff LL, Witjes BB, et al. (2012). Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study. BMJ Open, 2(4)

45

Postma MJ . Dynamic modeling for pandemic influenza. Expert Rev Vaccines 2012; May;11(5):543-6.

46

Postma MJ , Boersma C. Flexibility of Markov modeling for clinical pharmacoeconomics: illustration for cost-effectiveness in early Parkinson's disease. Expert Rev Clin Pharmacol 2012; Jan;5(1):1-4.

47

Postma MJ , Kappelhoff BS, van Hulst M, Brouwers JRBJ. Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the Netherlands. J Med Econ 2012;15(5):878-86.

48

Pouwels KB , van Grootheest K. The rosiglitazone decision process at FDA and EMA. What should we learn? Int J Risk Saf Med 2012;24(2):73-80.

49

Pouwels KB , Visser ST, Hak E. Effect of pravastatin and fosinopril on recurrent urinary tract infections. J Antimicrob Chemother 2012; Oct 30; DOI: 10.1093/jac/dks419.

50

Rahamat-Langendoen JC , Tutuhatunewa ED, Scholvinck EH, Hak E, Koopmans M, Niesters HG, Riezebos-Brilman A. Influenza in the immediate post-pandemic era: A comparison with seasonal and pandemic influenza in hospitalized patients. J Clin Virol 2012; Jun;54(2):135-40.

51

Ravera S , Monteiro SP, de Gier JJ, van der Linden T, Gomez-Talegon T, Alvarez FJ. A European approach to categorizing medicines for fitness to drive: Outcomes of the DRUID project. Br J Clin Pharmacol 2012 Dec;74(6):920-31

52

Ravera S , Ramaekers JG, de Jong-van den Berg LTW, de Gier JJ. Are selective serotonin reuptake inhibitors safe for drivers? What is the evidence?. Clin Ther 2012; May;34(5):1070-83.

53

Ravera S , van Rein N, de Gier JJ, de Jong-van den Berg LTW. A comparison of pharmacoepidemiological study designs in medication use and traffic safety research. Eur J Epidemiol 2012; Jun;27(6):473-81.

54

Riphagen-Dalhuisen J , Gefenaite G, Hak E. Predictors of seasonal influenza vaccination among healthcare workers in hospitals: a descriptive meta-analysis. Occup Environ Med 2012; Apr;69(4):230-5.

55

Riphagen-Dalhuisen J, Kuiphuis JC, Proce AR, Luytjes W, Postma MJ,Hak E. Contributing factors to influenza vaccine uptake in general hospitals: an explorative management questionnaire study from the Netherlands. BMC Public Health 2012;12(1):11013489

56

Rozenbaum MH , De Cao E, Postma MJ. Cost-effectiveness of pertussis booster vaccination in the Netherlands. Vaccine 2012; Jun 27; [Epub ahead of print].

57

Rozenbaum MH , De Vries R, LE HH, Postma MJ. Modeling the impact of extended vaccination strategies on the epidemiology of pertussis. Epidemiol Infect 2012; Aug;140(8):1503-14.

58

Rozenbaum MH , van Hoek AJ, Fleming D, Trotter CL, Miller E, Edmunds WJ. Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. BMJ 2012 Oct 26;345:e6879. DOI: 10.1136/bmj.e6879.

59

Rozenbaum MH, Pechlivanoglou P, van der Werf TS, Lo-Ten-Foe JR, Postma MJ,Hak E. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis 2012;3488

60

Rozenbaum MH and Postma MJ. Response on "RE: Cost-effectiveness of pertussis booster vaccination in the Netherlands". Vaccine 2012;3491

61

Stevanovic J , Postma MJ, Pechlivanoglou P. A systematic review on the application of cardiovascular risk prediction models in pharmacoeconomics, with a focus on primary prevention. Eur J Prev Cardiol 2012; Aug;19(2 Suppl):42-53.

62

ter Horst PG , Bos HJ, de Jong-van den Berg LTW, Wilffert B. In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children. Eur J Clin Pharmacol 2012; Jul 20; [Epub ahead of print].

63

ter Horst PG , van der Linde S, Smit JP, den Boon J, van Lingen RA, Jansman FG, De Jong-van den Berg LT, Wilffert B. Clomipramine concentration and withdrawal symptoms in 10 neonates. Br J Clin Pharmacol 2012; Feb;73(2):295-302.

64

ter Horst PG, Wilffert B, Tapper V, et al. The applicability of the brief medication questionnaire (BMQ) in pregnant women using antidepressants. Br J Clin Pharmacol. 2012;73(2):316-316.

65

Tu HA, de Vries R, Woerdenbag HJ, Li SC, Le HH, Phan TL, van Hulst M, Postma MJ. Cost-effectiveness of hepatitis B immunization in Vietnam: application of affordability curves in decision making. Value in Health (Regional Issue) 2012;Issues 1:7-14.

66

Tu HA, Riewpaiboon A, Woerdenbag HJ, Le HH, Le MD, Phan TL, Postma MJ, Li SC. Cost-of-illness of chronic hepatitis B in Vietnam. Value in Health (Regional Issue) 2012;(1):23-8.

67

Tu HA , Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries. Vaccine 2012; Feb 14;30(8):1521-8.

68

Tu HA , Vu HD, Rozenbaum MH, Woerdenbag HJ, Postma MJ. A review of the literature on the economics of vaccination against TB. Expert Rev Vaccines 2012; Mar;11(3):303-17.

69

van Hasselt FM , Coehorst Y, Wilffert B, Loonen AJ. Influencing CYP Enzymes to Boost Psychiatric Treatment: A Review on Clinical Evidence. Pharmacopsychiatry 2012; Oct 4; [Epub ahead of print].

70

van Hasselt FM , Schorr SG, Mookhoek EJ, Brouwers JRBJ, Loonen AJ, Taxis K. Gaps in health care for the somatic health of outpatients with severe mental illness. Int J Ment Health Nurs 2012; Jul 5; DOI: 10.111/j.1447-0349.2012.00859.x

71

van Hunsel F , Harmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf 2012; Jan 1;35(1):45-60.

72

van Ojik AL , Jansen PA, Brouwers JRBJ, van Roon EN. Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids. Drugs Aging 2012; Aug 1;29(8):615-25.

73

Vegter S , Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 2012; Jan;23(1):165-73.

74

Vegter S, Tolley K, Keith MS, Lok CE, Soroka SD,Morton AR. Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective. Clin Ther 2012;34(7):1531-433495

75

Vehof J , Burger H, Wilffert B, Al Hadithy A, Alizadeh BZ, Snieder H, GROUP investigators. Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genes. Eur Neuropsychopharmacol 2012; Sep;22(9):625-31.

76

Vu DH , Bolhuis MS, Koster RA, Greijdanus B, de Lange WC, V Altena R, Brouwers JR, Uges DR, Alffenaar JW. Dried blood spot analysis for therapeutic drug monitoring of linezolid in MDR-TB patients. Antimicrob Agents Chemother 2012 Nov;56(11):5758-63

77

Vu DH , van Rein N, Cobelens FG, Nguyen TT, Le VH, Brouwers JR. Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam, Int J Tuberc Lung Dis 2012;16:1625-9.

78

Wang H , Bos JH, de Jong-van den Berg LTW. Co-prescription of antiepileptic drugs and contraceptives. Contraception 2012; Jan;85(1):28-31.

79

Wang H , Bos JH, de Jong-van den Berg LTW. Reply to the Letter to the Editor on "Co-prescription of Antiepileptic Drugs and Contraceptives". Contraception 2012 Nov;86(5):594-5.

80

Westra TA , Parouty M, Brouwer WB, Beutels PH, Rogoza RM, Rozenbaum MH, Daemen T, Wilschut JC, Boersma C, Postma MJ. On discounting of health gains from human papillomavirus vaccination: effects of different approaches. Value Health 2012; May;15(3):562-7.

81

Woerdenbag HJ , Nguyen TM, Vu DV, Tran H, Nguyen DT, Tran TV, De Smet PA, Brouwers JRBJ. Vietnamese traditional medicine from a pharmacist's perspective. Expert Rev Clin Pharmacol 2012; Jul;5(4):459-77.

82

Zetstra-van der Woude PA , Vroegop JS, Bos HJ, de Jong-van den Berg LTW. A population analysis of prescriptions for asthma medications during pregnancy. J Allergy Clin Immunol 2012; Oct 11; DOI: 10.1016/j.jaci.2012.08.027. [Epub ahead of print].

Scientific publication national

1

Brouwers JRBJ, Visser E, Beinema MJ. Aanbevelingen over anticoagulantia: alternatieven voor het advies van de gezondheidsraad. Ned Tijdschr Geneesk 2012;156;A5123:413.

2

Brouwers JRBJ, Visser E, Beinema MJ. Commentaar. Aanbeveling over orale anticogulantia. Alternatieven voor het advies van de gezondheidsraad. Ned Tijdschr Geneesk 2012:156:A5203.

3

Bulsink A, Boor SD, Imholz ALT, Brouwers JRBJ, Jansman FGA. Inventarisatie van potentieel geneesmiddelgerelateerde problemen bij oncologiepatiënten (ONCOMIND). Pharmaceutisch Weekblad. Wetenschappelijk Platform2012;6:85-8

4

Smid DJ , de Jong-van den Berg LTW, Cornel MC. Foliumzuursuppletiebeleid bij zwangerschap werkt, maar moet beter [Peri-pregnancy folic acid supplementation must be improved.] Ned Tijdschr Geneeskd 2012;156(41):A4512.

5

Loonen AJM. Receptorafwijking verklaart bijwerking bij ziekte van Parkinson. Pharmaceutisch Weekblad. Wetenschappelijk Platform2012;6:84.

6

Pouwels KB. Statines en het risico op infecties. Pharmaceutisch Weekblad. Wetenschappelijk Platform 2012;6:e1209.

7

Risselada AJ, Vehof J, Bruggeman R, Wilffert B, Cohen D, Al Hadithy AF, Arends J, Mulder H. De associatie tussen HTR2C-polymorfismen en de prevalentie van het metabool syndroom bij patiënten die antipsychotica gebruiken: een replicatiestudie. Pharmaceutisch Weekblad. Wetenschappelijk Platform 2012;6:190-194.

8

Spijkers KM, Knuif LEM, van Lingen RA, Taxis K, van Herpen THM. Neonaten-IC: controle interacties blijft achter. Medicatiebewaking kan stuk beter. Pharmaceutisch Weekblad. Wetenschappelijk Platform 2012;6

9

te Brummelstroete GH, de Bruyn WF, Vegter S, Schuiling-Veninga CCM, Postma MJ. Kosteneffectiviteit van influenzavaccinatie bij ouderen met inclusie van indirecte medische kosten. Pharmaceutisch Weekblad. Wetenschappelijk Platform 2012;6(5):74-8

10

van den Tweel AM, van hunsel FPAM, Derijks HJ, Hermens WAJJ, van Puijenbroek EP, van Grootheest AC. Onderzoek naar het effect van een digitale meldmodule op het aantal gemelde bijwerkingen in een algemeen ziekenhuis, Pharmaceutisch Weekblad. Wetenschappelijk Platform 2012;6:79-84.

11

van Hunsel F, van der Welle C, Passier A, van Puijenbroek, E., & van Grootheest, K. (2012). Motieven voor het melden van bijwerkingen door patiënten in nederland. Pharmaceutisch Weekblad.Wetenschappelijk Platform 2012;6(10):162-167.

12

van hunsel FPAM , Kampschoër PHNM. Postmenopauzaal bloedverlies en voedingssupplementen. Ned Tijdschr Geneeskd 2012;156:A5095.

13

van Loveren FMAM, Weersink RA, Bos HJ, de Jong-van den Berg LTW, & Schuiling-Veninga CCM. (2012). Opgelucht ademhalen! geen verband tussen het gebruik van hormonale anticonceptiva voor de zwangerschap en de ontwikkeling van astma bij het kind. Pharmaceutisch Weekblad.Wetenschappelijk Platform 2012;6(3):45-49.

14

Vegter S, de Boer P, van Dijk KW, Visser ST, de Jong-van den Berg LTW. Artsen en apothekers miskennen vaak een door ACE-remmers geïnduceerde prikkelhoest, wat de therapietrouw verlaagt, Pharmaceutisch Weekblad. Wetenschappelijk Platform 2012;6(10):177-80.

15

Vegter S, Hiddink E, Stuurman-Bieze A, Postma M. De waarde van therapietrouw, Pharmaceutisch Weekblad. Wetenschappelijk Platform 2012;6(1):1-18.

16

Vogel D, van de Laar MAFJ, Jansen TL, Haagsma CJ, Reinders MK, Brouwers JRBJ, van Roon EN. Associatie tussen serumconcentratie oxipurinol en succesvolle behandeling van jichtpatiënten met allopurinol. Pharmaceutisch Weekblad. Wetenschappelijk Platform 2012;6(3)41-45.

17

Wilffert B. Farmacogenetica en de dagelijkse praktijk, Pharmaceutisch Weekblad. Wetenschappelijk Platform 2012;6:37.

Professional
1

Brouwers JRBJ, Visser E. Nieuwe antistollingsmiddelen: Bloedproef voor de patiëntrelevantie-inbreng patiënten bij beoordeling medicijnen moet beter. Cordiaal 2012;5:160-162

2

Brouwers JRBJ. Price Orphan drugs can be reduced drastically. PW (Pharmaceutical Weekly) 2012;39:12-15.

3

Feenstra TL, Krabbe PFM, Buskens EJ, Postma MJ. (2012). Doelmatigheid, kosteneffectiviteit studies en geneesmiddelenbeleid. MFM-4Tijdschrift Over Praktijkgerichte Farmacotherapie, 2(2), 42-47.

4

Postma MJ. Kosteneffectiviteit afhankelijk van levensverwachting. De Eerste Lijns 2012;7:24-5.

5

Postma MJ. Is het nieuwe geneesmiddel zijn geld waard?. De Eerste Lijns 2012;6:15-6.

6

Postma MJ. Kosteneffectiviteit en vergoeding van geneesmiddelen. De Eerste Lijns 2012;5:18-9.

7

Spijkers KM, Knuif LEM, van Lingen RA, Taxis K,van Herpen THM. Neonaten-IC: controle interacties blijft achter. Medicatiebewaking kan stuk beter. 2012;45

8

Van der Velde RY, Brouwers JRBJ, Geusens PP, Lems WF, van den Bergh JPW. Calcium en vitamine D-suppletie:nieuwe inzichten met belangrijke implicaties voor de dagelijkse praktijk. Osteopoprose Journal Juni 2012, p.8-16.

9

van Grootheest AC. Farmacovigilantie - Is het melden van bijwerkingen zinvol? Ned Tijdschr Dermatol Venereol 2012;22:156-8.

10

van Hunsel F. Altruïsme drijft patiënt bij meldingen Lareb. Pharm Weekbl 2012;147:20-23.

11

van Hunsel F, Dijkers FW. Benauwdheid als bijwerking van geneesmiddelengebruik. Bijblijven 2012;28:47-52.

12

Vegter S. Effectiviteit acupunctuur bij opvliegers bij borstkanker is niet aangetoond. Foliolum 2012;5:6

Book (whole)
1

Brouwers JRBJ (hoofdredacteur). Farmacotherapeutisch Kompas 2012, Uitgaaf CVZ 2012 Diemen-Z ISBN 978 9085 621 096.

2

Hoàng Thị Kim Huyền, JRBJ Brouwers. (Eds.) Handbook of Clinical Pharmacy. DƯỢC LÂM SÀNG NHỮNG NGUYÊN LÝ CƠ BẢN VÀ SỬ DỤNG THUỐC TRONG ĐIỀU TRỊ. (In two volumes). Chapters by: JRBJ Brouwers, JJ de Gier, AC van Grootheest, FGA Jansman, LTW de Jong-van den Berg, AJM Loonen, MJ Postma, K Taxis & B Wilffert.

Book (chapter)
1 Brouwers JRBJ, van der Hooft C. Hoofdstuk 23. de patiënt met beperkte therapietrouw. In: Probleem georiënteerd denken in de geriatrie onder redactie van M.G.M. Olde Rikkert et al. 2e druk, 2012. De Tijdstroom, Utrecht ISBN 978 90 5898 2100
2 De Gier JJ. Risk communication about drugs and driving. In: Müller K, Dittman V, Schubert W. (Eds), Fehlverhalten als Unfallsfaktor- Kriterien und Methoden der Risikobeurteilung. Kirchbaum Verlag Bonn.
3

de Gier JJ. Medicines & driving: results of the European DRUID project. In: A.Z. Tsfasman. (Ed), Железнодорожная медицина и профессиональная биоритмология. Railway medicine and occupational biorhythmology 2012;17-49

4 Krabbe P, Postma MJ & Buskens EJ. Keuzen in de zorg. In Bakker DJ, Post D, Polder J & Verkerk M. (Eds.), Een vitale toekomst. Onze gezondheidszorg in 2040. 2012 (Chapter 19:pp. 181-191). Amsterdam: Reed Business.
5 Postma MJ & Hubben GAA. The role of pharmacoecoinformatics in enhancing the pharmacoeconomics context of decision making. In Tagelsir Mohamed Gasmelseid (Ed.), Pharmacoinformatics and drug discovery technologies: Theories and applications. 2012 (Chapter 4:pp. 44-52). Hershey: Medical Information Science Reference (IGI Global).
6

van Grootheest AC & Richesson RL. Pharmacovigilance. In: van Richesson RL, Andrews JE. (Eds.), Clinical Research Informatics. 2012 (Chapter 19:pp. 367-388). London: Springer.

Laatst gewijzigd:19 april 2016 09:34